You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

Psoriatic arthritis
Original article
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

 

Online download statistics by month:

Online download statistics by month: March 2018 to March 2024

AbstractFullPdf
Mar 2018510511187
Apr 2018456464152
May 2018293307117
Jun 2018226226110
Jul 2018208208123
Aug 201820720790
Sep 2018767636
Oct 201811111179
Nov 2018848481
Dec 2018929254
Jan 201915815731
Feb 2019989838
Mar 201911311245
Apr 2019676739
May 2019808049
Jun 2019828137
Jul 2019858632
Aug 2019606042
Sep 2019575741
Oct 2019666739
Nov 2019777443
Dec 2019868647
Jan 2020898945
Feb 2020878731
Mar 2020858536
Apr 2020737320
May 202011111134
Jun 2020606025
Jul 2020595633
Aug 2020615250
Sep 2020939348
Oct 2020918734
Nov 2020787582
Dec 2020676634
Jan 2021736641
Feb 2021635841
Mar 2021635945
Apr 2021535059
May 2021474620
Jun 2021807147
Jul 2021545335
Aug 2021757137
Sep 2021807361
Oct 2021848445
Nov 2021585734
Dec 2021847934
Jan 2022657041
Feb 20229810049
Mar 2022787846
Apr 2022545431
May 2022798437
Jun 202211411744
Jul 2022646428
Aug 2022939125
Sep 2022625831
Oct 2022666526
Nov 2022787746
Dec 2022535017
Jan 2023596337
Feb 2023848344
Mar 2023585237
Apr 2023747137
May 2023615730
Jun 2023797740
Jul 2023686634
Aug 2023323121
Sep 2023665925
Oct 2023565417
Nov 2023443714
Dec 2023575711
Jan 2024191916
Feb 2024565524
Mar 2024535057
Total683067513348